- Red Light Holland (TRIP) receives patent-pending status For ‘Find Your Dose’ customization of microdosing kits based on biometric and movement data
- Evidence for the benefits of psilocybin continues to accumulate, and people who microdose psilocybin-containing mushrooms report improvements in mood, focus, creativity, and general well-being
- Meanwhile, acceptance of psilocybin continues to spread, with voters in Oregon legalizing the use of psilocybin and psilocybin-containing fungi for therapy
- Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles to the legal market within the Netherlands
- Red Light Holland Corp. (TRIP) is up 3.33 per cent and is trading at C$0.31 at 12:05 pm ET
Red Light Holland Corp. (TRIP) has received patent pending status for the customization and personalization of microdosing kits.
This consists of raw, natural and unprocessed magic truffles.
“Utilizing this data to help people find the psilocybin microdose that works best for them can potentially be a breakthrough in personalization of wellness applications,” said Sarah Hashkes, Red Light Holland’s Chief Technology and Innovation Officer.
“Working with natural substances and combining them with cutting edge innovation and proprietary technology to hopefully help people as opposed to limiting people, is now the way of the future,” added Todd Shapiro, CEO and Director of Red Light Holland.
“Learning about these potential benefits and being a part of developing precise dosages for the betterment of consumers is now a more realistic goal for Red Light Holland,” concluded Shapiro.
Red Light Holland’s newest innovation also incorporates the ground-breaking advancements in its iMicro Digital Care App and its Wisdom Truffle, further contributing to a growing technology ecosystem designed to allow consumers to obtain the greatest possible benefit from their microdosing journeys.
Evidence for the benefits of psilocybin continues to accumulate, and people who microdose psilocybin-containing mushrooms report improvements in mood, focus, creativity, and general well-being, as well as the amelioration of symptoms of mental health issues.
Meanwhile, acceptance of psilocybin continues to spread, with voters in Oregon legalizing the use of psilocybin and psilocybin-containing fungi for therapy, and numerous other jurisdictions moving toward legalization or decriminalization.
Despite this growing body of evidence, and despite the increasing acceptance of its use both as a medicine and for the betterment of healthy people, little is currently known about how dosage amounts and protocols can be optimized for specific individuals.
This is particularly true in the case of microdosing, and those interested in achieving the benefits of microdosing must generally rely on trial and error, or expensive coaches, and there is no assurance that either will lead to optimal outcomes.
Working to overcome these hurdles, ongoing research by inventor Sarah Hashkes, CTIO of Red Light Holland, has resulted in a novel approach to microdosing, which enables personalized dosing amounts and protocols that are based on collected biometric and movement data.
It is also correlated with the qualities and characteristics of Red Light Holland’s natural products.
Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, and in compliance with all applicable laws.
Red Light Holland Corp. (TRIP) is up 3.33 per cent and is trading at C$0.31 at 12:05 pm ET.
